Research programme: peptide mimics - Mimetica

Drug Profile

Research programme: peptide mimics - Mimetica

Alternative Names: GPCR mimetics - Mimetica; Peptide mimetic scaffolds - Mimetica; Peptide mimetics - Mimetica

Latest Information Update: 31 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mimetica
  • Class Peptides; Small molecules
  • Mechanism of Action G protein-coupled receptor modulators; Melanocortin receptor antagonists; Peptide receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Cancer; Inflammation; Obesity; Skin disorders

Most Recent Events

  • 31 Dec 2015 No recent reports on development identified - Preclinical for Skin disorders in Australia (unspecified route)
  • 07 Feb 2011 Preclinical development for Skin disorders is ongoing (Australia)
  • 07 Feb 2011 No development reported - Preclinical for Cancer in Australia (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top